Influence of caffeine on pharmacokinetic profile of sodium valproate and carbamazepine in normal human volunteers

Indian Journal of Experimental Biology

Volumn 36, Issue 1, 1998, Pages 112-114

  Vaz, Julius ^a   Kulkarni, Chanda ^a   David, Joy ^a   Joseph, Thangam ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CARBAMAZEPINE; EPILEX; UNCLASSIFIED DRUG; VALPROIC ACID;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INTERACTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN;

ANTICONVULSANTS; CAFFEINE; CARBAMAZEPINE; CROSS-OVER STUDIES; DRUG INTERACTIONS; EPILEPSY; HUMANS; MALE; VALPROIC ACID;

EID: 0031951118     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Holtzman S G, Trends Pharmacol Sci, 11 (1990) 355.
2. Jokela S & Vartiainen A, Acta Pharmacol, 15 (1959) 331.
3. Kulkarni C, Joseph T & David J, Indian J Exp Biol, 27 (1989) 1048.
4. Kulkarni C, Joseph T & David J, Indian J Exp Biol, 29 (1991) 751.
5. Kulkami Chanda, Vaz Julius, David Joy & Joseph Thangam, Indian J Physiol Pharmacol, 39 (1995) 122.
6. Gerson B, Bell F & Chan S, Clin Chem, 30 (1984) 105.
7. Sundar Rao P S S, Jesudian G & Richard J, An introduction to biostatistics, (Department of Biostatistics, C.M.C., Vellore), 1978, 82.
8. Minaly G W, Vajda F J, Miles J L & Luis W J, Eur J Clin Pharmacol, 16 (1979) 23.
9. Gilman A G, Rall T W, Neis A S & Taylor P, Goodman and Gilman's The pharmacological basis of therapeutics,(Pergamon Press, U S A), 8th Ed, 1990, 436.
10. Weitholtz H, Zysset T, Kreiten K, Kohl D, Buchsel R & Matern, Eur J Clin Pharmacol, 36 (1989) 401.